ABT-737 Key Intermediate Synthesis Using Boc Protection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for preparing the key intermediate of ABT-737 face challenges due to the poor stability of N-fluorenylmethyloxycarbonyl protective groups, leading to low product yield and difficulty in synthesizing in large quantities, along with the use of toxic reagents and complex purification processes.

Innovation Solution

A method using a tert-butoxycarbonyl protective group is introduced, involving esterification, reduction, vulcanization, hydrolysis, amination, deprotection, and carbonyl reduction reactions, which stabilizes the intermediate and allows for higher yields and simplifies the process by using low-toxicity reagents like thiophenol metal salts and diphenyl disulfide, reducing the complexity of purification and operational costs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If N-fluorenymethyloxycarbonyl protective group is used, then the synthesis method is conventional and well-established, but the intermediate exhibits poor stability and product yield is low

Engineering Contradiction:
Improveintermediate stabilityVSAvoidproduct yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent changes the protective group from N-fluorenymethyloxycarbonyl to tert-butoxycarbonyl, fundamentally altering the chemical parameters of the intermediate. This parameter change results in improved stability of the intermediate and higher product yield, directly resolving the contradiction between reliability and productivity.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If traditional synthesis route is used, then the method is well-established, but the process is complex and requires toxic reagents

Engineering Contradiction:
Improveprocess simplicityVSAvoidtoxicity of reagents
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces toxic reagents with low-toxicity alternatives. Specifically, it uses dimethylamine instead of more toxic aminating agents, and employs low-toxicity reducing agents in the carbonyl reduction step. This substitution reduces harmful factors while maintaining ease of manufacture.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent converts potentially harmful reactions into beneficial ones by optimizing reaction conditions and selecting greener reagents. The carbonyl reduction under acidic conditions with low-toxicity reducing agents transforms a potentially hazardous step into a safe and efficient process, reducing environmental impact while maintaining productivity.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Ease of manufacture

If N-fluorenymethyloxycarbonyl protective group is used, then the synthesis follows conventional protocol, but purification process becomes complex and costly

Engineering Contradiction:
Improvepurification easeVSAvoidpurification process complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The change in protective group from N-fluorenymethyloxycarbonyl to tert-butoxycarbonyl fundamentally alters the physical and chemical properties of intermediates, making them easier to purify. This parameter change simplifies the purification process, reducing both complexity and cost, and directly addresses the contradiction between ease of manufacture and device complexity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high yields of the key intermediate with improved stability and reduced toxicity, facilitating easier synthesis and purification, and offers a more cost-effective and industrially viable process compared to traditional methods.

Implementation Method 1

subjecting the active ester and a first reducing agent to a reduction reaction to obtain a compound having a structure represented by formula II

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

subjecting the compound having a structure represented by formula II, a vulcanizing agent, and an organic phosphine to a vulcanization reaction to obtain a compound having a structure represented by formula III

Methodology Applied
Scientific EffectVulcanization: Chemical Bonding

Implementation Method 3

subjecting the compound having a structure represented by formula III to a hydrolysis reaction under an alkaline condition to obtain a hydrolysate

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 4

subjecting the hydrolysate and dimethylamine to an amination reaction to obtain a compound having a structure represented by formula IV

Methodology Applied
Scientific EffectAmination: Chemical Bonding

Implementation Method 5

subjecting the compound having a structure represented by formula IV to a deprotection reaction with a deprotection reagent to obtain a deprotected product

Methodology Applied
Scientific EffectDeprotection: Decomposition (biological)

Implementation Method 6

subjecting the compound having a structure represented by formula V and a second reducing agent to a carbonyl reduction reaction under an acidic condition to obtain the key intermediate of ABT-737

Methodology Applied
Scientific EffectCarbonyl reduction: Reduction

Data Source

PatentUS20240140923A1Method for Preparing Key Intermediate of ABT-737 and Method for Preparing ABT-737
Publication Date: 2024.05.02 XEON BIOPHARMACEUTICAL LTD
  • US20240140923A1 patent drawing
  • US20240140923A1 patent drawing
  • US20240140923A1 patent drawing

AI summary

The present disclosure relates to the technical field of drug synthesis, and provides a method for preparing a key intermediate of ABT-737 and a method for preparing ABT-737. In the present disclosure, the compound having a structure represented by formula I is used as the starting material. The carboxyl group in the compound having a structure represented by formula I is first reduced to a hydroxyl group, followed by a vulcanization by a vulcanizing agent, and then an amination, a deprotection, a condensation, and a carbonyl group reduction, to obtain the key intermediate of ABT-737 having a structure represented by formula VI. Tert-butoxycarbonyl is used as the protecting group for the compound having a structure represented by formula I, and the subsequent intermediate containing the protecting group of tert-butoxycarbonyl is stable, and easy to be deprotected. This method is suitable for mass synthesis, with high product yield and low production cost, and thus has a good industrialization prospect.